Publication | Closed Access

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

Refractory NeuroblastomaMedicineMetronomic TherapyCancer-siop-european Neuroblastoma StudyNeurologyHigh-grade GliomasEuropean Innovative TherapiesCancer TreatmentOncologyRadiation OncologyCancer Research